Authors

• Tahir Abbas (ORCID: https://orcid.org/0000-0002-0968-3261)
• Petr Kavan (ORCID: https://orcid.org/0000-0002-6836-8333)
• X. Lucy
• F. Aubin (ORCID: https://orcid.org/0000-0002-1421-4996)
• Sheryl Koski (ORCID: https://orcid.org/0000-0003-0255-7200)
• John R. Goffin (ORCID: https://orcid.org/0000-0003-1696-8342)
• Christopher O’Callaghan (ORCID: https://orcid.org/0000-0002-8633-2473)
• Hagen Fritz Kennecke (ORCID: https://orcid.org/0000-0002-3211-0656)
• Félix Couture
• Emma Titmuss (ORCID: https://orcid.org/0000-0002-1993-6912)
• Dongsheng Tu (ORCID: https://orcid.org/0000-0003-4842-2184)
• Derek J. Jonker (ORCID: https://orcid.org/0009-0008-1103-3429)
• Jonathan M. Loree (ORCID: https://orcid.org/0000-0001-8189-2132)
• Eric X. Chen (ORCID: https://orcid.org/0000-0002-4581-8848)
• Nathalie Aucoin
• Benoit Samson
• Chaudhary E. Ahmad
• Scott Berry
• Setareh Samimi
• Mohammed Harb
• Bruce Colwell (ORCID: https://orcid.org/0009-0008-6780-4368)

Institutions

• Queen's University (CA)
• Moncton Hospital (CA)
• Juravinski Cancer Centre (CA)
• Queen Elizabeth II Health Sciences Centre (CA)
• Trillium Health Centre (CA)
• Ottawa Hospital (CA)
• Providence Portland Medical Center (US)
• Princess Margaret Cancer Centre (CA)
• Saskatchewan Cancer Agency (CA)
• Hôpital Charles-Le Moyne (CA)
• Alberta Cancer Foundation (CA)
• Hôtel-Dieu de Québec (CA)
• St. John’s Health Sciences Centre (CA)
• Hôpital du Sacré-Cœur de Montréal (CA)
• Centre Hospitalier de l’Université de Montréal (CA)
• Ottawa Hospital Research Institute (CA)

Publication Details

Journal

Journal for ImmunoTherapy of Cancer

Published

2024-12-01

DOI

https://doi.org/10.1136/jitc-2024-010094

Citations

2

Primary Topic

Cancer Immunotherapy and Biomarkers

Type

article

Field-Weighted Citation Impact

0.57

Funders

• Amgen
• Bristol-Myers Squibb
• AstraZeneca
• Taiho Pharmaceutical
• Exelixis
• Natera
• Eisai